Multidisciplinary records review
Complex Cancer Second Opinions from Multi-Expert Academic Panels
Complex cancer decisions can involve pathology, molecular findings, surgery, radiation, systemic therapy, sequencing, and clinical-trial questions at the same time. A multi-expert panel is designed to show where academic specialists converge, where they differ, and what evidence or assumptions explain the difference.
Diagnostic Detectives Network at a glance
A row-ready summary
Model
Independent multi-expert academic panel selected for the cancer type, stage, molecular profile, prior treatment, and unresolved decision.
Panel design
Panels for complex cancer cases combine surgical, radiation, and medical oncology perspectives (typically two experts per modality on the six-expert tier).
Deliverable
The written report typically exceeds 50 pages and includes expert rationale, answers to the client's questions, and references to the underlying research.
Price and boundary
Pricing starts from €6,000 per case; the exact quote depends on panel size and complexity. Records-based and informational; no examination, treatment, emergency care, or physician-patient relationship.
Why several disciplines
One case can contain several different expert questions
The appropriate mix is case-specific. The point is not to maximize the number of reviewers; it is to include the disciplines needed to examine the actual choice.
Pathology and molecular interpretation
Confirm what has been established by tissue review and testing, what remains uncertain, and whether the available classification is sufficient for the treatment question.
Surgical strategy
Assess whether an operation is feasible, what its goal would be, how timing matters, and which procedure-specific expertise and institutional support are relevant.
Radiation strategy
Examine whether radiation has a role, the treatment intent and timing, and how it interacts with surgery, systemic treatment, prior radiation, and surrounding structures.
Systemic therapy
Review standard options, sequencing, biomarker-dependent choices, prior response and toxicity, and whether a trial question is sufficiently specific to investigate.
Before expert matching
Build one coherent case record
Confirm the source material
Collect pathology reports, relevant slides or digital pathology when requested, imaging in the required format, molecular reports, operative notes, treatment summaries, and current laboratory data.
Construct the timeline
Record diagnosis, procedures, therapies, response assessments, complications, and the present recommendation in chronological order. Missing dates or unclear treatment sequences can change how evidence is interpreted.
State the decision
Ask questions that can be answered from the record: whether the diagnosis or stage needs further verification, which reasonable paths exist, where evidence is strong, and what additional information would change the choice.
How disagreement is reported
Consensus, minority view, and unresolved divergence
Consensus
Experts reach substantially the same conclusion and explain the evidence supporting it. The report records the shared view without presenting agreement as a guarantee.
Minority view
Most experts favor one path while one or more favor another. The report preserves the minority rationale and identifies the assumptions behind the difference.
Divergence
Reasonable experts remain divided, evidence is immature, or the choice depends on values and tradeoffs. The report makes the uncertainty explicit and identifies information that could narrow it.
Limits matter
What a remote panel cannot do
A records review cannot examine the patient, provide urgent assessment, guarantee that every data point is complete, or direct treatment. It can clarify the evidence, expose assumptions, and help the client prepare a focused discussion with the treating oncology team.
Questions about cancer panels
Frequently asked questions
How is a multi-expert cancer panel different from one hospital second opinion?
A hospital program usually provides the view of one specialist or one institutional team. An independent panel deliberately selects several academic reviewers for the case and compares their written reasoning, including disagreement. Either can be appropriate depending on the decision.
How many experts are needed for a complex cancer case?
There is no universal number. The panel should reflect the unresolved questions and disciplines involved. Diagnostic Detectives Network panels generally include 3-10+ experts; a six-expert cancer panel may include two reviewers from each of three relevant oncology modalities.
Can a panel identify a clinical trial?
Experts may discuss trials relevant to the exact condition and decision, but eligibility cannot be confirmed from a general records review alone. Trial criteria, geography, timing, testing, and the treating team's assessment still need direct verification.
Should treatment wait for a second opinion?
That is a clinical timing decision for the treating team. A remote panel is not an emergency service. Clients should ask their physicians whether a review can occur without unsafe delay and should never postpone urgent treatment based on website information.
Free expert library
Continue with recorded academic expert conversations
A considered next step
Discuss whether an independent panel fits the decision
You can begin with a short conversation or send a confidential inquiry. Do not send private medical records until Diagnostic Detectives Network confirms the appropriate intake path.
Prepared for medical review by Anton Titov, MD, PhD
Last verified: July 11, 2026
Diagnostic Detectives Network is a research-grade informational service — it is not telemedicine, establishes no physician-patient relationship, and is not for emergencies. Decisions about diagnosis or treatment remain with the client and their treating physicians.